Procaps Group SA (PROC)
2.95
+0.37
(+14.34%)
USD |
NASDAQ |
May 17, 16:00
2.95
0.00 (0.00%)
After-Hours: 16:35
Procaps Group Revenue (TTM): 414.10M for Sept. 30, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | 414.10M |
| June 30, 2023 | 406.09M |
| March 31, 2023 | 408.45M |
| December 31, 2022 | 409.92M |
| September 30, 2022 | 434.99M |
| June 30, 2022 | 431.42M |
| Date | Value |
|---|---|
| March 31, 2022 | 417.93M |
| December 31, 2021 | 409.74M |
| September 30, 2021 | 401.35M |
| June 30, 2021 | 373.84M |
| March 31, 2021 | 356.80M |
| December 31, 2020 | 331.47M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
331.47M
Minimum
Dec 2020
434.99M
Maximum
Sep 2022
399.67M
Average
409.10M
Median
Revenue (TTM) Benchmarks
| Alvotech | 91.43M |
| Moolec Science SA | -- |
| Perspective Therapeutics Inc | 0.00 |
| Electromed Inc | 53.50M |
| Xtant Medical Holdings Inc | 91.30M |